[Contribution 2] Explanation of the ‘Digital Medical Products Act’ for pharmaceutical practitioners - Focusing on the revised law system
Attorney Daeryun Lee Il-hyung "special legal character...Establishment of an independent system distinct from existing medical device laws"business license, clinical trial, Performance evaluation, advertising regulations, Real-world evaluation,In a previous contribution, the contributor looked at the growth potential of the digital medical device market and said,, ‘Digital Medical Products Act’ Explained the necessity of the enactment and the purpose of the legislation.. In particular, it emphasizes the characteristics of digital medical technology that are difficult to include in the existing medical device law system., It has been pointed out that the establishment of an independent regulatory system was inevitable.. The Digital Medical Products Act, enacted against this background, has its own legal system that is distinct from existing laws.. Below, we will focus on the overall framework and legal system of the Digital Medical Products Act.. 1. Relationship between the existing legal system and the Digital Medical Products Act Digital Medical Products Act(Briefly below ‘Dongbeop’)is a medical device under the existing legal system., In vitro diagnostic medical devices, medicine, Products that were classified as industrial products, etc. are converted into digital medical devices., Digital convergence medicine, It is reclassified and defined as digital medical and health support devices.. for example, Before the enactment of this law AI Diagnostic software with applied technology is considered a medical device under the Medical Device Act., Digital convergence medicine is a pharmaceutical and/Or, it is regulated as a medical device under the Medical Device Act, but, Under the Digital Medical Products Act, all ‘digital medical products’, Among them, each ‘digital medical devices’ and ‘Digital convergence medicine’It is stipulated that. Below, in accordance with the Medical Device Act, ‘medical device’definitions and regulations of ‘Digital Medical Products Act’ By comparing definitions, Let’s take a closer look at the differences in concept between the two laws.. As can be seen from the comparison table above, the law ‘digital technology’(Intelligent information technology, robot technology, Advanced technologies prescribed by Prime Minister’s Ordinance, such as information and communication technology)The phrase is key.. in other words, This law stipulates medical devices using digital technology., Convergence medicine, medical treatmentㆍHealth support devices are defined as digital medical products.. The existing legal system, the Medical Device Act,, Looking at the relationship with the Pharmaceutical Affairs Act, The Digital Medical Products Act functions as a kind of special law., ‘digital technology’If the unique requirements of. the other side, to the product ‘digital technology’If this is not included, existing medical device laws, Pharmaceutical Affairs Act, In vitro diagnostic medical device method, Or, it would be easier to understand that laws related to industrial products apply.. Meanwhile, among digital medical products ‘digital medical devices’Regarding whether it applies to, You can easily make a decision by using the chart below attached to the guidelines published by the Ministry of Food and Drug Safety.. 2. As explained earlier, the regulatory system of this law is different from the existing law., The background to the enactment of this law is 'digital technology'This is because the existing legal system has limitations in effectively regulating this new technology due to its characteristics that distinguish it from existing medical devices.. for example, Because digital medical device software does not exist in physical form,, According to the existing medical device law ‘seal’ There is no need to apply relevant regulations. also, In the case of digital medical products, the performance of the finished product can be predicted relatively accurately when made by combining proven components.. This law reflects these characteristics, e case ‘seal’ Without applying relevant regulations, In the latter case, it is stipulated that the licensing process can be simplified if the finished product is designed only with verified elements that have undergone component performance evaluation..As such, this law was designed to have an independent regulatory system that is different from existing laws., An overview of the main differences from the existing regulatory system is as follows.. Business license management: Introducing a separate business licensing system that reflects the characteristics of digital technology -Digital medical device manufacturing business that manufactures or imports digital medical devices ㆍ Establishment of new import industry regulations(Same law8article, my12article)-Special provisions regarding the sale of stand-alone digital medical device software(Same law27article) Streamline clinical trials: Introduction of simplified clinical trial procedures reflecting the characteristics of digital technology-IRB and the scope of clinical trials that require approval from the Minister of Food and Drug Safety are expected to differ.(Prime Minister's Decree). -Allows for new types of clinical trials, such as data-based clinical trials(Same law9Preparation5port) Component performance evaluation: Establishment of a component performance evaluation system to reflect the characteristics of digital medical products, which often consist of multiple components -The Minister of Food and Drug Safety can evaluate the performance of components that may affect the function of digital medical products, such as sensors and artificial intelligence algorithms. -If the license applicant constructs a finished product using only components for which performance evaluation has been completed, ‘Simplification of licensing procedures’You can receive the benefit of(Same law40Preparation1From clause 1 to 13port, my5term, etc.). Benefits of Excellent Management System Certification -currently being discussed 'Regulations on digital medical product licensing, certification, reporting, review and evaluation, etc.'According to, Same law17Preparation3Manufacturers who have received good management system certification pursuant to this clause may receive special privileges.. (specifically, legislation24pharmacy1Antibiotics4Materials corresponding to the 'Information about the product(model design, Input/output data, development information, etc.)', 'Actual use evaluation plan', 'Actual use evaluation result report'It is expected that it will be possible to submit it in place of ..) Establishment of new regulations related to professional software -For professional software “For professional use” mark, Sales channel, Regulations on advertising methods, etc.(Same law21From the first to the third23article) In the case of stand-alone digital medical device software, exceptions to some provisions of the Medical Device Act are recognized.: Clarifies that unnecessary regulations do not apply to standalone software -Regarding stand-alone digital medical device software, ‘Medical Device Act’ my13pharmacy2port(Obligation to report production performance of medical devices, etc.), my18condolences5(Open sales prohibited), my19article(Scope of application for medical devices, shape or structure, Test specifications, Standard specifications for written information, etc.), my25condolences5(seal), my29From the first to the third31Until the moment(Medical devices subject to tracking management, Creation and Retention of Records, Side Effect Management), my31condolences2(Report on medical device supply details, etc.), my31condolences5(Report on the discovery of foreign substances in medical devices, etc.) and first49article(Renewal of manufacturing license, etc.)does not apply. -In addition, considering the characteristics of stand-alone digital medical device software, 「Medical Device Act」The same also applies in cases where the Minister of Food and Drug Safety recognizes that it is appropriate not to apply.(Same law28article). Real-world evaluation -Regarding actual use evaluation, Despite the rebate-related provisions of the Medical Device Act, a significant exception provision has been established to provide digital medical devices.. Furthermore, digital medical device manufacturers, etc. are also given the benefit of being able to use actual use evaluation data in various approval procedures.. -Digital medical device manufacturers, etc. collect data in the process of actually using digital medical devices.ㆍEvaluate the safety and effectiveness of digital medical devices based on the generated information(below “Real-world evaluation”It is called)can do(Same law15Preparation1port). -Digital medical device manufacturers, etc. who wish to conduct an actual use evaluation must collect the data necessary for the actual use evaluation. 「Medical Device Act」 my13pharmacy3Notwithstanding the provisions of this Article, medical practitioners or those who establish medical institutions within the scope prescribed by Ordinance of the Prime Minister.(Representative or director of a corporation, Also includes those engaged in this.) Digital medical devices subject to evaluation may be provided to medical institution workers. In this case, digital medical device manufacturers, etc. may request medical personnel, medical institution founders, and medical institution workers who use the digital medical devices subject to evaluation to view records of use of the digital medical devices or provide copies thereof.(Same law15article). -The Minister of Food and Drug Safety provides actual use evaluation data submitted by digital medical device manufacturers, etc.8pharmacy3Manufacturing license according to paragraphㆍManufacturing CertificationㆍManufacturing report, my11Permission for change according to ArticleㆍChange CertificationㆍReport change, my12pharmacy2Import permission pursuant to paragraphㆍImport CertificationㆍCan be used for import declaration, etc.(Same law15Preparation3term, etc.). 3. Summary Since the Digital Medical Products Act has a special legal nature, ‘digital technology’If this applies, this Act shall apply.. This Digital Medical Products Act reflects the characteristics of digital technology and is building an independent system that is distinct from the existing medical device law.. specifically, business license, clinical trial, Performance evaluation, advertising regulations, Real-world evaluation, It has unique regulations such as component-based licensing.. Meanwhile, as mentioned at the beginning, Because the contents of the Digital Medical Products Act are so extensive, it was not possible to summarize all the contents in this article.. In the next series, we plan to cover detailed provisions and practical explanations in depth., We urge pharmaceutical company practitioners to continue to pay attention.. I would like to end this contribution here.. [View full article]
[Contribution 2] Explanation of the ‘Digital Medical Products Act’ for pharmaceutical practitioners - Focusing on the revised law system (Shortcut)